Biopure Oxyglobin Case Summary

Good Essays
How best to exploit the opportunity presented by Oxyglobin without jeopardizing the potential of Hemopure is a tough problem for Biopure’s executive. According to the financial analysis, it is suggested that Biopure begin to sell Oxyglobin at $150 per unit to emergency care practice at the Veterinary Blood Market and have its own distribution network. This will make a profit of $5 million at first year and $17 million thereafter. The steadfast income will consolidate Biopure’s financial structure and enhance the competiveness of Hemopure. The potential annual values are $794 & $135 million for Hemopure & Oxyglobin respectively. The human blood substitutes market would be monopoly if only Hemopure released, so the Oxyglobin influence …show more content…
Therefore, launching Oxyglobin is a support rather than a threat. The marketing strategy of Oxyglobin will be mentioned below.

First, Biopure has to concentrate on the emergency care market instead of primary care market since the research shows relatively higher gross revenue in emergency care practices despite the rare 5% frequency. In addition, the annual requirement of blood transfusion in emergency care practices is approximately 900,900 units, which exceed 300,000 units – the capacity of Oxyglobin. In other words, the whole Oxyglobin can be successfully sold out because of the deficit blood supply. Furthermore, pet owners are more willing to pay for emergency care than pay for primary care. Therefore, Biopure can only focus its target on emergency care practices market in the initial stage. Second, $150 per unit is a proper price for Oxyglobin because of the results offered by the pet owners’ and veterinarians’ surveys. The results indicated that $150 and $300 per unit are willingly accepted by veterinarian and pet owner when most clients face critical cases. Aside from that, a pet owner will pay $130 to $170 per unit in a typical emergency care practice under the “donor animal” system. Oxyglobin at $150 can

You May Also Find These Documents Helpful

  • Good Essays

    Biopure Case Summary

    • 847 Words
    • 4 Pages

    Biopure's two products, Hemopure for human use, and Oxyglobin for animal veterinary use, both represented a new blood substitute based treatment for managing patients' oxygen requirements in a broad range of potential medical applications. The main issue that is plaguing Biopure is how the possible launch of Oxyglobin will affect the future launch and pricing strategies of Hemopure, which could provide a larger return for their investment.…

    • 847 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Biopure Case Summary

    • 1918 Words
    • 8 Pages

    Biopure's greatest strength lies in its ability to market its blood substitute technology for both animal and human use. Further, Biopure has the patents and FDA approval to forge ahead in the animal market with a two-to-five year time buffer from new competition (using similar technology). One of the company's weaknesses is that it has not received FDA approval on Hemopure, and there are two other companies that could beat Biopure to the market with similar products. But if the FDA does not approve Hemopure, which could have the potential to cripple a single product biopharmaceutical company, the company may still withstand such a disruption with Oxyglobin sales and future research and development. Another weakness is the uncertainty of market acceptance for Hemopure, in the face of a deeply-rooted blood donation network.…

    • 1918 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    Oxyglobin Case

    • 621 Words
    • 3 Pages

    To assess what price Oxyglobin should be set at, we must analyze the 4 C's. Firstly, in evaluating the company, we determine that the cost of production is $15 Million per year independent of volume, plus $1.50 per unit variable cost. The current capacity for Oxyglobin is 300,000 units. In exhibits 4 and 5 we determine their break-even cost.…

    • 621 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    Biopure case memo

    • 451 Words
    • 2 Pages

    launch of Hemopure. We also feel that animal and human markets are sufficiently removed from one…

    • 451 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Biopure Case

    • 1372 Words
    • 6 Pages

    Problem Definition In February 1998 Biopure Corporation faced a difficult decision regarding the launch of its newly developed “blood substitute” products. Biopure had developed “Hemopure”, a blood substitute for humans, and an ancillary product “Oxyglobin” for the veterinary market1. Hemopure was still in the process of gaining Federal Drug Administration (FDA) approval , while Oxyglobin had already been approved and was ready to be launched1. FDA approval was estimated to be two years away2, but this could change as the approval process is inherently complex and uncertain. The main problem Biopure faced was whether to launch Oxyglobin now, or wait until Hemopure was approved and launch both products simultaneously. This was a complex problem as the early launch of Oxyglobin would have both positive and negative repercussions for Biopure. These repercussions needed to be carefully analysed in order to decide what the best course of action is. Another problem was that Biopure had competitors with similar human blood substitute products in the pipeline 3 . Biopure have to consider how to position and price their products in relation to their competitors. An additional problem exists in the pricing of Oxyglobin and Hemopure in order to appeal to their respective markets4. Lastly, Biopure has no current cashflow and therefore needs to be successful with its upcoming IPO in order to raise the requisite cash and solidify its future5. Analysis Human blood is an extremely important commodity as it is used for blood transfusion procedures. However, blood collection is becoming increasingly difficult because donor rates are falling and a lot of collected blood is being discarded due to contamination or expiry6. Biopure identified a need for a “blood substitute” product which would provide the following benefits7: 1) eliminate the need for blood typing and cross matching, 2) free from infectious agents and contamination and 3) increased…

    • 1372 Words
    • 6 Pages
    Good Essays
  • Satisfactory Essays

    Gm 533 Statistics

    • 284 Words
    • 2 Pages

    The company management has decided to market this product if the expected contribution to profit for the next six months is more than $90,000. Based on the information given above, should the company begin manufacturing the new drug?…

    • 284 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Tengion Case Study

    • 262 Words
    • 2 Pages

    Comments: Finding a business opportunity is an art. And Medicines Company thrives upon this unique idea of developing abandoned drugs which still have some remaining value for the market. One such drug is Angiomax which is a blood thinning drug or anticoagulant. Main reasons for selecting Angiomax were its effectiveness over existing drug Heparin, another alternative to the only drug Heparin available for angioplasty and the cost to produce the Angiomax could be reduced to half making it economically viable business. After getting FDA approval, the management board of Medicines Company is facing go to market pricing issues with Angiomax and their inability to come up with a right price for the drug. The main reason for the current pricing problem is already existing widely used competitor drug Heparin, which is priced only at $2/dose. In order to position Angiomax in the market Medicines Company have to analyse its advantages and economic value in comparison to Heparin.…

    • 262 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    The purpose of this article is to figure out the most efficient way for Loblaw to open up new business in pharmaceutical industry. We believe that acquisition is the best.…

    • 821 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Angiomax Case

    • 2260 Words
    • 10 Pages

    After 4 years hard working, 30 million dollars in acquiring Angiomax, further R&D, and initiate marketing test, in order to successfully market the first flagship drug Angiomax, the Medicines Company now have a couple of decisions to make in terms of initial pricing, segmentation, marketing strategies, etc (see exhibit 1).…

    • 2260 Words
    • 10 Pages
    Powerful Essays
  • Good Essays

    In case of this company they have tried to combine the mutually supportive capabilities. They have tried to develop a business model by integrating the drug line and the production capabilities. Furthermore, packaging is arranged as a line hybrid process.…

    • 830 Words
    • 4 Pages
    Good Essays
  • Good Essays

    Biopure Case Study

    • 935 Words
    • 4 Pages

    The key issue is to determine when Oxyglobin should be introduced to the market without jeopardizing Hemopure’s potential and how it should be marketed.…

    • 935 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    Biopure

    • 386 Words
    • 2 Pages

    * Their products Oxyglobin and Hemopure are blood substitutes for the animal and the human market respectively.…

    • 386 Words
    • 2 Pages
    Satisfactory Essays
  • Best Essays

    Berman, K. E. (2011, JAN nd). international blood/plasma news. Retrieved NOV 6, 2011, from marketingresearchbureau.com: http://www.marketingresearchbureau.com/IBPN_Jan_2011.pdf…

    • 2118 Words
    • 9 Pages
    Best Essays
  • Satisfactory Essays

    Blood transfusion. Blood and blood component transfusions is an important routine medical procedure in small animal medicine especially in emergency cases (Fragio and Daza, 2013).…

    • 181 Words
    • 1 Page
    Satisfactory Essays
  • Better Essays

    According to Wikipedia, blood is a specialized bodily fluid that delivers necessary substances to the body’s cells, such as nutrients and oxygen, and transports waste products away from those same cells (Wikipedia, 2011). There has been a high demand for blood, all types of blood. Statistically speaking someone in the United States needs blood every two seconds (Rare Blood Types, 2010). Due to the high need for blood, scarcity plays a role with blood donation. This paper will discuss how scarcity resources influence the market, and the choices stakeholders are forced to make. The essay will also relay the economic flows that may affect the health care market, the causes of change in supply and demand and the affects of equilibrium price and quantity, and the pricing decisions for blood donations with elasticity or inelasticity.…

    • 972 Words
    • 4 Pages
    Better Essays